European Society for Medical Oncology Molecular Analysis for Precision Oncology Congress 2023
Format: 52 videos + 38 pdfs, size: 4.62 GB
Course Audience: oncologist
Overview:
- Start date: 04 Oct 2023
- End date: 06 Oct 2023
- Location: Paris, France
The Molecular Analysis for Precision Oncology Congress (MAP) 2023 took place from 4 to 6 October 2023 in Paris, France.
MAP is a congress designed to provide the latest data in the field of precision oncology, molecular profiling and personalised medicine.
The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers.
Our globally recognised experts in clinical and precision oncology welcomed delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.
The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.
The partner societies had the pleasure of introducing a special day on 6 October 2023: “RoadMAP to the Clinic 2023: From organ specific to biomarker driven drug development and approval”. Society experts and stakeholders from the scientific community, regulatory and HTA authorities, patient advocates, methodological experts and pharmaceutical industry representatives participated in sessions comprising lectures and brainstorming discussion on this year’s theme ”How to transform development and registration of precision therapeutics in oncology from organ-specific to histology-agnostic and biomarker driven approvals”, in order to achieve molecularly informed, resource-rational and timely enrichment of the therapeutic armamentarium for our patients.
Clonal evolution Identifying the drivers of cancer and clonal hematopoiesis by evolution-based methods (Video MP4 Format)
Clonal evolution Identifying the drivers of cancer and clonal hematopoiesis by evolution-based methods (PDF Format)Clonal evolution Mathematical modelling to develop insights into cancer evolution (Video MP4 Format)Clonal evolution Mathematical modelling to develop insights into cancer evolution (PDF Format)Clonal evolution Q&A (Video MP4 Format)Conference Calendar – Molecular Analysis for Precision Oncology Congress 2023 (PDF Format)Ecology of cancer Cancer-type-specific fungal ecologies and bacteriome (Video MP4 Format)Ecology of cancer Cancer-type-specific fungal ecologies and bacteriome (PDF Format)Ecology of cancer Q&A (Video MP4 Format)Gordon Peters keynote lecture Introduction to the keynote lecture (Video MP4 Format)Gordon Peters keynote lecture Introduction to the keynote lecture (PDF Format)Immunotherapy Breast cancer Immunotherapy- Role of tissue resident memory cells (Video MP4 Format)Immunotherapy Breast cancer Immunotherapy- Role of tissue resident memory cells (PDF Format)Immunotherapy Q&A (Video MP4 Format)Immunotherapy T cell eosinophil crosstalk during response to immune checkpoint blockade (Video MP4 Format)Immunotherapy T cell eosinophil crosstalk during response to immune checkpoint blockade (PDF Format)Keynote lecture Role of neutrophils in tumour metastases (Video MP4 Format)Keynote lecture Role of neutrophils in tumour metastases (PDF Format)Molecular characterisation Multi modal single cell characterization of cancers and WGS (Video MP4 Format)Molecular characterisation Multi modal single cell characterization of cancers and WGS (PDF Format)Molecular characterisation Q&A (Video MP4 Format)Molecular characterisation Single cell epigenomics in tumour progression (Video MP4 Format)Molecular characterisation Single cell epigenomics in tumour progression (PDF Format)Molecular characterisation Spatial resolution in molecular characterization- Impact of cancer heterogeneity in treatment (Video MP4 Format)Molecular characterisation Spatial resolution in molecular characterization- Impact of cancer heterogeneity in treatment (PDF Format)New trial designs, new paths to drug registration Biomarker-driven immunotherapies- How relevant is being tumour type-specific (Video MP4 Format)New trial designs, new paths to drug registration Biomarker-driven immunotherapies- How relevant is being tumour type-specific (PDF Format)New trial designs, new paths to drug registration DRUP (Drug Repurposing) trial and beyond- Learning from DRUP 1.0 (Video MP4 Format)New trial designs, new paths to drug registration DRUP (Drug Repurposing) trial and beyond- Learning from DRUP 1.0 (PDF Format)New trial designs, new paths to drug registration Fast-tracking preclinical research to pan-cancer trials- Success stories and less so (Video MP4 Format)New trial designs, new paths to drug registration Fast-tracking preclinical research to pan-cancer trials- Success stories and less so (PDF Format)New trial designs, new paths to drug registration Introduction (Video MP4 Format)New trial designs, new paths to drug registration Introduction (PDF Format)New trial designs, new paths to drug registration Pre-clinical development of targeted agents- Change of mindset from tumour (Video MP4 Format)New trial designs, new paths to drug registration Pre-clinical development of targeted agents- Change of mindset from tumour (PDF Format)New trial designs, new paths to drug registration Q&A 1 (Video MP4 Format)New trial designs, new paths to drug registration Q&A 2 (Video MP4 Format)New trial designs, new paths to drug registration Towards harmonised design and interpretation of histology agnostic, biomarker driven trials (Video MP4 Format)New trial designs, new paths to drug registration Towards harmonised design and interpretation of histology agnostic, biomarker driven trials (PDF Format)Proffered Paper session 1 Are targeted therapies effective in the relapsed or metastatic cancer setting A Cochrane meta-analysis (Video MP4 Format)Proffered Paper session 1 Are targeted therapies effective in the relapsed or metastatic cancer setting A Cochrane meta-analysis (PDF Format)Proffered Paper session 1 Deciphering resistance mechanisms in cancer- Insights from the final report of MATCH-R study with focus on molecular drivers (Video MP4 Format)Proffered Paper session 1 Deciphering resistance mechanisms in cancer- Insights from the final report of MATCH-R study with focus on molecular drivers (PDF Format)Proffered Paper session 1 Dissecting intratumoral heterogeneity in localized HR+HER2- breast cancer using single-cell DNA sequencing (scDNA-seq) (Video MP4 Format)Proffered Paper session 1 Dissecting intratumoral heterogeneity in localized HR+HER2- breast cancer using single-cell DNA sequencing (scDNA-seq) (PDF Format)Proffered Paper session 1 Invited discussant 1 (Video MP4 Format)Proffered Paper session 1 Invited discussant 1 (PDF Format)Proffered Paper session 1 Invited discussant 2 (Video MP4 Format)Proffered Paper session 1 Invited discussant 2 (PDF Format)Proffered Paper session 1 Q&A 1 (Video MP4 Format)Proffered Paper session 1 Q&A 2 (Video MP4 Format)Proffered Paper session 2 Invited discussant 1 (Video MP4 Format)Proffered Paper session 2 Invited discussant 1 (PDF Format)Proffered Paper session 2 Invited discussant 2 (Video MP4 Format)Proffered Paper session 2 Invited discussant 2 (PDF Format)Proffered Paper session 2 Q&A (Video MP4 Format)RoadMAP to the Clinic 2023 The current landscape of research and development (R&D) and approval of precision therapeutics- The challenge of optimisation (Video MP4 Format)RoadMAP to the Clinic 2023 The current landscape of research and development (R&D) and approval of precision therapeutics- The challenge of optimisation (PDF Format)RoadMAP to the Clinic 2023 Welcome and objectives (Video MP4 Format)Sarcoma Clinical utility of next-generation sequencing in sarcomas (Video MP4 Format)Sarcoma Clinical utility of next-generation sequencing in sarcomas (PDF Format)Sarcoma Immunotherapy for sarcomas (Video MP4 Format)Sarcoma Immunotherapy for sarcomas (PDF Format)Sarcoma Q&A (Video MP4 Format)Technology of radiation FLASH radiation therapy (Video MP4 Format)Technology of radiation FLASH radiation therapy (PDF Format)Technology of radiation Molecular determinants of radiosensitivity and implications on multi-modality therapy (Video MP4 Format)Technology of radiation Molecular determinants of radiosensitivity and implications on multi-modality therapy (PDF Format)Technology of radiation Q&A (Video MP4 Format)Technology of radiation Real-time, image guided, adaptive radiotherapy- Advances in precision radiation oncology (Video MP4 Format)Technology of radiation Real-time, image guided, adaptive radiotherapy- Advances in precision radiation oncology (PDF Format)The next wave of pan-cancer clinical trials Panel discussion (Video MP4 Format)The next wave of pan-cancer clinical trials The future of the tissue agnostic targets (Video MP4 Format)The next wave of pan-cancer clinical trials The future of the tissue agnostic targets (PDF Format)The next wave of pan-cancer clinical trials Wrap-up and roadmap for actions (Video MP4 Format)The next wave of pan-cancer clinical trials Wrap-up and roadmap for actions (PDF Format)Tumour microenvironment Overview and microenvironment of metastasis (Video MP4 Format)Tumour microenvironment Overview and microenvironment of metastasis (PDF Format)Tumour microenvironment Q&A (Video MP4 Format)Welcome to the MAP Congress 2023 (Video MP4 Format)Welcome to the MAP Congress 2023 (PDF Format)What are the current roadblocks to histology Design and running of biomarker-driven pan-cancer trials- Methodological perspectives (Video MP4 Format)What are the current roadblocks to histology Design and running of biomarker-driven pan-cancer trials- Methodological perspectives (PDF Format)What are the current roadblocks to histology Q&A (Video MP4 Format)What are the current roadblocks to histology The patient perspective on pan-cancer trials and access to drugs (Video MP4 Format)What are the current roadblocks to histology The patient perspective on pan-cancer trials and access to drugs (PDF Format)What are the current roadblocks to histology The regulator perspective on biomarker and test development (EMA) (Video MP4 Format)What are the current roadblocks to histology The regulator perspective on biomarker and test development (EMA) (PDF Format)What are the current roadblocks to histology The regulator perspective on pan-cancer drug development (FDA) (Video MP4 Format)What are the current roadblocks to histology The regulator perspective on pan-cancer drug development (FDA) (PDF Format)